The number of foreign patients travelling to China for treatment remains small, Yicai reported, despite social media posts that describe the country filling with medical tourists as its visa-free entry rules relax. Most of the foreigners now using Chinese hospitals are expatriates who already live and work in the country, the outlet said, rather than patients who flew in for care. That gap between the online picture and the recorded numbers is the whole of the story.
Expatriates, not arrivals
That pattern shows in the numbers Yicai gathered. The International Medical Department of the Guangzhou Women and Children’s Medical Center, part of Guangzhou Medical University, has treated 152 foreign patients since it opened in July 2024, and most were foreign nationals already living and working in China rather than travellers who flew in for care. Wellness visits built on traditional Chinese medicine remain rarer again. Tania Mara Brasileiro, from Brazil, took traditional Chinese medicine treatments with her family of six on a first trip to China in December 2025, but a local tour guide surnamed Zhang told Yicai that such health tourism was uncommon among foreign visitors. Guangzhou has separately promoted a new international medical tourism service centre, the kind of official push that runs ahead of the recorded arrivals.
A net exporter of patients
China has long sat on the other side of the ledger. About 800,000 Chinese citizens travel abroad for medical treatment each year, Yicai reported, which makes the country one of the world’s largest sources of outbound medical demand, a figure the World Travel and Tourism Council set out in its report ‘A Prescription for a Healthier Economy’. Its pull in the other direction stays weak, and the deficit in the cross-border balance will take sustained work to close. Cai Qiang, chairman of Saint Lucia Consulting, said his firm began late last year to channel patients from neighbouring countries into Chinese hospitals, working with the international departments of leading hospitals in Beijing and Shanghai. Cai said the number of overseas patients reaching China was ‘almost negligible’ beside the more than one million South Korea receives each year.
What holds the numbers down
Several barriers keep inbound numbers low, Yicai reported, and insurance is the first. The director of the lymphoma department at an oncology hospital in northern China described a patient from Venezuela with chronic lymphocytic leukaemia whose private insurance would not cover China’s innovative drugs; the out-of-pocket cost proved too high, the treatment could not go on, and the leukaemia went untreated. Visa length is the second barrier. A standard tourist visa allows a stay of about 30 days, and Cai said serious illness often needs longer, which makes the current rules too short for patients who need longer treatment or recovery. Cross-border payment of medical bills and foreign insurance cover both remain thin, the outlet said, adding friction to a journey patients can take elsewhere with less. The relaxed visa-free entry that the social media posts credited is real, but it covers short stays, not the months a serious case can demand.
The buzz and the balance
The case for optimism is real but slow. China’s clinical standards are rising, new drugs reach its market faster than before, and looser visa rules make short stays easier, all of which Yicai counted as genuine draws. Awareness is the missing piece, the outlet said, because many patients abroad still do not know what Chinese hospitals can do. What matters is the distance between that potential and today’s arrivals. Most of the foreigners in Chinese hospitals today are resident expatriates, the outlet found, not medical tourists who flew in for care. Buzz measures attention; the balance measures patients, and the two have not yet met. A destination is proven when recorded arrivals rise, not when a video travels.
The tests are countable. Whether the Guangzhou department’s 152 foreign patients grows into a much larger figure in its next report, whether hospitals in Beijing and Shanghai publish inbound numbers that separate resident expatriates from genuine arrivals, and whether a dedicated medical visa replaces the 30-day tourist stay will show whether China is closing the deficit or still exporting it.
